Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial.

Nat Commun · 2022 · PMC8987042 · PMID 35388003

Europe PMC DOI

hedged sentence

0.0580

closest p · 1.2× alpha

0.0580

boldest claim

The sentences

marginally insignificantp = 0.058so close (0.05 < p ≤ 0.1)

others) was marginally insignificant ( p = 0.058).

also in 511 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.